Immediate Impact
1 by Nobel laureates 9 from Science/Nature 59 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Biomedical SERS – the current state and future trends
2024 Standout
Works of Kan Kishibe being referenced
Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery
2021
Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Kan Kishibe | 756 | 488 | 525 | 88 | 1.5k | |
| Yan Gao | 668 | 511 | 273 | 112 | 1.6k | |
| Luigi Chiusa | 789 | 329 | 280 | 76 | 2.2k | |
| Atsuo Mikata | 689 | 951 | 315 | 111 | 1.9k | |
| Yuko Mishima | 496 | 499 | 231 | 112 | 1.5k | |
| Kung‐Chao Chang | 711 | 560 | 361 | 101 | 2.0k | |
| Robert Pytlík | 461 | 441 | 265 | 90 | 1.5k | |
| Suzuko Moritani | 320 | 333 | 239 | 108 | 1.8k | |
| Maike Büttner‐Herold | 691 | 92 | 757 | 107 | 1.7k | |
| Delphine Rolland | 583 | 655 | 285 | 41 | 1.9k | |
| Eva Geissinger | 849 | 1156 | 636 | 78 | 2.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...